Boaz Mizrahi

Practice Areas

Joint Ventures, Spin Offs and Corporate Restructurings

Private Equity

Venture Capital

Hi-Tech/Start ups

Commercial Transactions

Information Technology / Licensing

Life Sciences

Medical Devices and Biotechnology

Outsourcing of Business Systems

Climatech

Career

Boaz Mizrahi is a leading partner in the firm’s Corporate, Hi-Tech, and Technology group. With over 25 years experience, Boaz is renowned for his strategic counsel in technology and intellectual property law, representing many of Israel's leading startups emerging growth companies, particularly healthcare, pharmaceuticals, biotech, life sciences, FoodTech, and climate tech sectors.

Boaz has a distinguished track record in structuring and negotiating complex licensing agreements—especially in life sciences, technology, FoodTech, and spin-offs from universities and medical centres. He leads all IP and commercial aspects for many of the firm’s clients in the life sciences and healthcare fields, including numerous license deals with academic institutes, hospitals, and commercial companies, as well as other collaborations between entities.

His expertise extends to a broad range of commercial and strategic transactions, including acquisitions, asset purchase agreements, partnerships, development initiatives, technology transfer agreements, strategic alliances, and joint ventures. Boaz's comprehensive skillset enables clients to succeed throughout the commercialization lifecycle—from research and development, evaluations, and pre-clinical and clinical trials, to licensing, manufacturing, distribution, and sales.

Boaz is known for his ability to navigate complex technology transactions with insight and precision. His deep industry knowledge, practical approach, and familiarity with key legal and business personnel at TTOs of academic institutes and hospitals in Israel provide a significant advantage to clients. He is a trusted advisor to clients seeking to drive innovation, achieve strategic growth, and capitalize on emerging opportunities in the healthcare and life sciences sectors, supporting their continued success.